References
- Appelbaum FR, Gundacker H, Head DR, . Age and acute myeloid leukemia. Blood 2006;107:3481–3485.
- Büchner T, Berdel WE, Haferlach C, . Age-related risk profile and chemotherapy dose response in acute myeloid leukemia:a study by the German Acute Myeloid Leukemia Cooperative Group. J Clin Oncol 2009;27:61–69.
- Estey E. Acute myeloid leukemia and myelodysplastic syndromes in older patients. J Clin Oncol 2007;25:1908–1915.
- Löwenberg B, Suciu S, Archimbaud E, . Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy—the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group. J Clin Oncol 1998;16:872–881.
- Rowe JM, Neuberg D, Friedenberg W, . A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group. Blood 2004;103:479–485.
- Larson ML, Venugopal P. Clofarabine:a new treatment option for patients with acute myeloid leukemia. Expert Opin Pharmacother 2009;10:1353–1357.
- Kantarjian HM, Jeha S, Gandhi V, . Clofarabine: past, present, and future. Leuk Lymphoma 2007;48:1922–1930.
- Mayer RJ, Davis RB, Schiffer CA, . Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med 1994;331:896–903.
- Cox KM, Goel S, O'Connell RL, . A randomized crossover trial comparing inpatient and outpatient administration of high dose cisplatin. Intern Med J 2010 Feb 26. [Epub ahead of print].
- Halim TY, Song KW, Barnett MJ, . Positive impact of selective outpatient management of high-risk acute myelogenous leukemia on the incidence of septicemia. Ann Oncol 2007;18:1246–1252.
- Gardin C, Turlure P, Fagot T, . Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial. Blood 2007;109:5129–5135.
- Gómez-Almaguer D, Ruiz-Argüelles GJ, Ruiz-Argüelles A, . Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis: report of four cases. Bone Marrow Transplant 2000;25:131–133.
- Yamazaki K, Boku N, Shibamoto K, . The role of the outpatient clinic in chemotherapy for patients with unresectable or recurrent gastric cancer. Jpn J Clin Oncol 2007;37:96–101.
- Gillis S, Dann EJ, Rund D. Selective discharge of patients with acute myeloid leukemia during chemotherapy-induced neutropenia. Am J Hematol 1996;51:26–31.
- Zhenchuk A, Lotfi K, Juliusson G, . Mechanisms of anti-cancer action and pharmacology of clofarabine. Biochem Pharmacol 2009;78:1351–1359.
- Kantarjian HM, Erba HP, Claxton D, . Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors. J Clin Oncol 2010;28:549–555.
- Burnett AK, Russell NH, Kell J, . European development of clofarabine as treatment for older patients with acute myeloid leukemia considered unsuitable for intensive chemotherapy. J Clin Oncol 2010;28:2389–2395.
- Dressel A, Kwari M, McGreal AM. Nursing considerations for optimal outpatient management of adult patients with leukemia treated with clofarabine Clin J Oncol Nurs 2011;15:E13–E23.
- Girmenia C, Alimena G, Latagliata R, . Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit. Haematologica 1999;84:814–819.
- Rose PG, Lappas PT. Analysis of the cost effectiveness of concurrent cisplatin-based chemoradiation in cervical cancer: implications from five randomized trials. Gynecol Oncol 2000; 78:3–6.